Trivitron's Finnish Dx buy underscores trend of emerging players going global?
This article was originally published in Clinica
Indian medtech firm Trivitron Healthcare has become the latest emerging market player to expand outside its domestic market, acquiring Finnish in vitro diagnostics specialist Ani Labsystems for €15.8 million ($20.6 million), according to media reports. As well as bolstering its diagnostic offering, the deal also gives Trivitron access to a global manufacturing facility.
Register for our free email digests: